To preorder Bundibugyo RVPs, visit our page here.
Integral Molecular’s Bundibugyo Ebolavirus Reporter Virus Particles (RVPs) are replication-incompetent pseudotyped virus particles that enable safe (BSL-2), easy, and high-throughput viral infectivity and neutralization assays using standard detection instrumentation. Filovirus RVPs enable safe neutralization assays in BSL-2, enabling any lab to support the response to outbreaks and new threats.
The RVPs display ebolavirus glycoprotein based on the isolate from the 2007 outbreak in Uganda on a VSV core and carry a modified genome that expresses a convenient optical reporter gene within 24 hours of cellular infection. Protocols are provided for neutralization and infectivity assays.
For more details about RVPs, their applications, and answers to frequently asked questions, visit the Reporter Virus Particle Information page. For tips on setting up your own neutralization assay, visit Pseudovirus Neutralization Assays: A How-to Guide for Getting Started. To learn more about filovirus RVPs, visit Filovirus Reporter Virus Particles.
Looking for the 2026 outbreak isolate for Bundibugyo instead? RVPs for BDBV/Democratic_Republic_of_the_Congo/PP_006XHL9.2/2026-05-07 can be found here.
| Product | Bundibugyo Ebolavirus Reporter Virus Particles (RVPs) |
| Catalog Number | RVP-1425 |
| Strain | H.sapiens-tc/UGA/2007/Butalya-811250 |
| Accession ID | YP_003815435.1 |
| Packaging | 20% FBS/DMEM |
| Recommended Input Range | 1 μL per well (96-well plate) for ~20% infectivity in a flow assay |
| Target Cell Line | HEK-293T |
| Lead time | Ready to ship |
| Shipping | Shipped on dry ice |
| Storage conditions | Store at -80°C (+/- 10°C) upon receipt |
| Size | 1.0 mL/vial |
| Warranty | Terms and Conditions (pdf) |
| SDS | Ebola RVP SDS (pdf) |
| Protocols | |
| Technical Data Sheets | RVP Tech Data Sheets |
